MeSH D013174 - sporotrichosis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D003881:Dermatomycoses
0 Companies
0 Drugs
Success rate
D013174: 
Sporotrichosis
$
Success rate
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
MylanItraconazole Itraconazole  2012-07-20   
Mayne GroupItraconazole Tolsura 2023-07-25 2018-12-11   
Johnson & JohnsonItraconazole Sporanox  1992-09-11   
SandozItraconazole Itraconazole  2004-05-28   
Zydus TherapeuticsItraconazole Itraconazole  2017-09-19   
Alembic PharmaceuticalsItraconazole Itraconazole  2016-12-13   
Alkem LaboratoriesItraconazole Itraconazole  2017-06-12   
ApotexItraconazole Itraconazole  2019-08-02   
Torrent PharmaceuticalsItraconazole Itraconazole  2018-08-24   
1
2
3
>
Clinical Trials
Historical Success Rate
Phase 1
100%
1/1
Phase 2
0%
0/2
Phase 3
100%
3/3
Approved: 3Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
1
2
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use